Not applicableStudy completedNCT03078595What this trial is testingGingival Bleeding and Von Willebrand Disease Typ 2 and 3Who this might be right forGingival BleedingVon Willebrand Diseases Goethe University 48
Not applicableEnrolling By InvitationNCT03655223What this trial is testingEarly Check: Expanded Screening in NewbornsWho this might be right forSpinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more RTI International 30,000
Early research (Phase 1)Study completedNCT00816660What this trial is testingPharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand DiseaseWho this might be right forVon Willebrand Disease Baxalta now part of Shire 32
Large-scale testing (Phase 3)Looking for participantsNCT06998524What this trial is testingAssess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand DiseaseWho this might be right forVon Willebrand Disease, Type 3 Hoffmann-La Roche 75
Not applicableLooking for participantsNCT06883240What this trial is testingAn Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care TreatmentWho this might be right forVon Willebrand Disease, Type 3 Hoffmann-La Roche 40
Not applicableLooking for participantsNCT05437536What this trial is testingThe Severe Von Willebrand Disease (sVWD) Patient RegistryWho this might be right forVWD - Von Willebrand's Disease VWD Connect Foundation 400
Early research (Phase 1)Looking for participantsNCT05500807What this trial is testingEmicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia AWho this might be right forVon Willebrand Disease, Type 3Concomitant VWD and Hemophilia Bleeding and Clotting Disorders Institute Peoria, Illinois 40
Early research (Phase 1)Study completedNCT04770935What this trial is testingTo Assess the Pharmacokinetics and Safety and Tolerability of Efanesoctocog Alfa (BIVV001)in Adults With Type 2N and 3 Von Willebrand Disease (VWD)Who this might be right forVon Willebrand's Disease (VWD) Bioverativ, a Sanofi company 6
Post-approval studies (Phase 4)Active Not RecruitingNCT00555555What this trial is testingEfficacy of Alphanate FVIII/VWF Concentrate in Type 3 Von Willebrand PatientsWho this might be right forVon Willebrand Disease Grifols Biologicals, LLC 15
Not applicableStudy completedNCT02460458What this trial is testingType 3 Von Willebrand International Registries Inhibitor Prospective StudyWho this might be right forType 3 Von Willebrand's Disease Fondazione Angelo Bianchi Bonomi 265
Not applicableLooking for participantsNCT06610201What this trial is testingBleeding and Treatment in Participants With Von Willebrand DiseaseWho this might be right forVon Willebrand Disease (VWD)Von Willebrand Disease (VWD), Type 1Von Willebrand Disease (VWD), Type 2+4 more Hemab ApS 200